TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Hossein Borghaei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.